KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea flag South Korea · Delayed Price · Currency is KRW
698.00
+16.00 (2.35%)
At close: Sep 14, 2026

KMPHARMACEUTICAL Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3,771-3,968-4,573-1,320-3,925-611.19
Depreciation & Amortization
897.341,0101,3351,3691,4591,442
Loss (Gain) From Sale of Assets
3.5800.21-10.42--6.56
Asset Writedown & Restructuring Costs
---9.19808.27501.8
Loss (Gain) From Sale of Investments
1.42-0.3-13.98-9.92-13.93-0.61
Loss (Gain) on Equity Investments
252.64445.03403.23-64.8775.56674.08
Provision & Write-off of Bad Debts
-64.04-91.01248.02231.59301.7766.11
Other Operating Activities
326.11282.571,293-232.241,491331.07
Change in Accounts Receivable
-727.4298.41-41.36437.051,008-1,026
Change in Inventory
326.85275.48-374.791.94246.46123.75
Change in Accounts Payable
12.52249.98193.93166.16-632.95383.86
Change in Other Net Operating Assets
167.11-53.08-505.8868.64-912.03388.6
Operating Cash Flow
-2,575-1,751-2,0361,446-93.322,267
Operating Cash Flow Growth
-----149.37%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,252-258.11-365.1-112.77-57.69-2,365
Sale of Property, Plant & Equipment
--0.1110.63-33.58
Sale (Purchase) of Intangibles
-4.31-4.31-3.76-0.59--
Investment in Securities
23.94582.75-68.03-17.52366.36-745.84
Other Investing Activities
-0-451.141-19
Investing Cash Flow
-1,232316.32-385.63-119.25-5,091-8,058

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-4,5002,5005,5002,2005,000
Long-Term Debt Issued
-1,0004,0001,0004,0002,500
Total Debt Issued
8,1425,5006,5006,5006,2007,500
Short-Term Debt Repaid
--3,700-4,500-2,000-700-5,000
Long-Term Debt Repaid
--136-311.08-5,321-1,913-315.1
Total Debt Repaid
-4,200-3,836-4,811-7,321-2,613-5,315
Net Debt Issued (Repaid)
3,9421,6641,689-821.193,5872,185
Repurchase of Common Stock
-5.45-----
Other Financing Activities
--100-0--8610
Financing Cash Flow
3,9361,5641,689-821.193,5012,195

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.11-0.05-0.13-0.7
Net Cash Flow
128.62129.56-732.32505.62-1,684-3,596

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3,827-2,009-2,4011,333-151.02-97.92
Free Cash Flow Growth
------
Free Cash Flow Margin
-22.55%-12.56%-16.59%7.50%-0.97%-0.43%
Free Cash Flow Per Share
-137.22-72.04-86.0947.48-5.42-3.52
Levered Free Cash Flow
-3,038-1,271-1,1421,862-1,143-141.3
Unlevered Free Cash Flow
-2,642-899.7-778.382,246-902.32-32.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
626.38592.02578.23630.38349.01170.85
Cash Income Tax Paid
--0.03-0.23-5.3832.74-2.22
Change in Working Capital
-220.94570.79-728.021,474-290.14-129.63